Beyond BMI : The Impact of the New Lancet Commission Diagnostic Criteria on Prevalence of Obesity in the United States
Obesity · 2026-06 · 34 (S1) · 29-42
DOI: 10.1002/oby.70144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, online erschienen am 22.02.2026. Verfasst von Jennifer H Hwang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of General Internal Medicine, Department of Medicine, University of Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Obesity, Body Mass Index. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, University of Chicago, National Institutes of Health.
Abstract (Originalsprache)
Objective
This study compared population characteristics and overall US prevalence of obesity over time using the BMI criteria and the 2025 Lancet Commission criteria (i.e., the Excess Adiposity criteria).
Methods
We analyzed data from 58,053 adults aged ≥ 20 years in the National Health and Nutrition Examination Survey from 1999 to 2023. The Excess Adiposity criteria incorporated BMI, waist circumference, waist to hip and waist to height ratios, and body fat percentage to identify obesity, which was subclassified as preclinical or clinical based on organ dysfunction and activity limitations. Survey‐weighted estimates were calculated to produce nationally representative trends.
Results
By BMI criteria, obesity prevalence increased from 31% (58.8 million) in 1999–2004 to 43% (101.3 million) in 2021–2023. By Excess Adiposity criteria, prevalence was higher and increasing from 51% (94.7 million) to 61% (143.9 million). The prevalence of clinical obesity is high due to a large number of people meeting criteria for organ dysfunction and/or activity limitations.
Conclusions
Using the Excess Adiposity criteria to define obesity classifies nearly three in five US adults as having obesity, revealing substantial clinical, public health, and policy implications. The new criteria improve identification of individuals at risk but will require further strategies to achieve equitable, effective, and sustainable obesity prevention and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of General Internal Medicine, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
- Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois, USA.
ORCID-Profile: Jennifer H Hwang
Förderung
- NIH HHS
- University of Chicago
- National Institutes of Health
Zitieren
APA
Hwang, J. H., & Laiteerapong, N. (2026). Beyond BMI : The Impact of the New Lancet Commission Diagnostic Criteria on Prevalence of Obesity in the United States. Obesity, 34(S1), 29-42. https://doi.org/10.1002/oby.70144
Vancouver
Hwang JH, Laiteerapong N. Beyond BMI : The Impact of the New Lancet Commission Diagnostic Criteria on Prevalence of Obesity in the United States. Obesity. 2026;34(S1):29-42. doi:10.1002/oby.70144
BibTeX
@article{Hwang2026,
author = {Hwang, Jennifer H and Laiteerapong, Neda},
title = {Beyond BMI : The Impact of the New Lancet Commission Diagnostic Criteria on Prevalence of Obesity in the United States},
journal = {Obesity},
year = {2026},
volume = {34},
number = {S1},
pages = {29--42},
doi = {10.1002/oby.70144}
}
EUVIMED